HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bousson, V. Articles by Breau, J.-L. Search for Related Content PubMed PubMed Citation Articles by Bousson, V. Articles by Breau, J.-L.

Assessment of Malignancy in Pulmonary Lesions: FDG Dual-Head Coincidence Gamma Camera Imaging in Association with Serum Tumor Marker Measurement

Departments of Nuclear Medicine, Oncology, and Pulmonary Medicine, CHU, Paris, Bobigny; and Department of Statistics, CHU, Dauphine, France

The purpose of the study was to evaluate the performance of dual-head coincidence gamma camera imaging using FDG in association with serum marker assays in identifying lung carcinoma in patients with abnormal findings on chest radiography. Methods: A prospective evaluation of FDG imaging with coincidence detection emission tomography (CDET) using a dual-head gamma camera combined with the assessment of 3 sensitive serum markers of lung cancer (carcinoembryonic antigen, neuron specific enolase, and CYFRA 21-1) was performed on the same day on 58 consecutive patients with known or suspected lung malignancy. Results: Fifty-three patients were proven to have lung cancer, and 5 patients had benign lung disease. Coincidence imaging showed significantly increased FDG uptake in 49 of 53 patients with proven malignancy (sensitivity, 92.5%) and in 3 patients with benign disease. FDG imaging had negative findings in 4 patients with proven malignancy and 2 patients with benign disease. Serum tumor marker levels were elevated in 42 of 53 cancer patients (sensitivity, 79.2%) and normal in 11 patients with proven malignancy. Nine patients with proven malignancy had positive findings on FDG images and negative marker assays. Two patients with proven malignancy had negative findings on FDG images and positive marker assays. The positive predictive value for lung cancer was 94.2% for FDG alone and 97.6% for FDG in association with serum markers. Conclusion: In this study, FDG CDET imaging was a powerful tool for evaluating patients with lung lesions suggestive of malignancy. Although the determination of serum marker levels was less accurate than FDG imaging, positive FDG results found in association with positive markers significantly increased the likelihood of lung malignancy.

Key Words: FDG • dual-detector coincidence imaging • pulmonary lesions • serum markers

Received Sep. 8, 1999; revision accepted Mar. 2, 2000.

For correspondence or reprints contact: Jean-Luc Moretti, MD, PhD, Department of Nuclear Medicine, Avicenne Hospital, 125 rue de Stalingrad, Bobigny F 93009, France.

This article has been cited by other articles:

				P. S. Oturai, J. Mortensen, H. Enevoldsen, A. Eigtved, V. Backer, K. P. Olesen, H. W. Nielsen, H. Hansen, P. Stentoft, and L. Friberg {gamma}-Camera 18F-FDG PET in Diagnosis and Staging of Patients Presenting with Suspected Lung Cancer and Comparison with Dedicated PET J. Nucl. Med., August 1, 2004; 45(8): 1351 - 1357. [Abstract] [Full Text] [PDF]

				H. Stevens, P. F.A. Bakker, N. J.J. Schlosser, P. P. van Rijk, and J. M.H. de Klerk Use of a Dual-Head Coincidence Camera and 18F-FDG for Detection and Nodal Staging of Non-Small Cell Lung Cancer: Accuracy as Determined by 2 Independent Observers J. Nucl. Med., March 1, 2003; 44(3): 336 - 340. [Abstract] [Full Text] [PDF]

				E. Even-Sapir, H. Lerman, A. Figer, M. Rabau, G. Livshitz, M. Inbar, and M. Gutman Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma J. Nucl. Med., May 1, 2002; 43(5): 603 - 609. [Abstract] [Full Text] [PDF]